Parsippany, N.J.—A new study presented by James Elliott at the 9th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment meeting in Washington represented a breakthrough in the management of menopausal symptoms. The clinical study, conducted in collaboration with KGK Synergize Inc. London, Ontario, was a randomized, placebo-controlled, double blind design in which 84 healthy postmenopausal women were given either geniVida® or a placebo. After 12 weeks the women on geniVida had a 51-percent reduction on hot flashes and night sweats compared to only 27 percent for the women in the placebo.
Lynda Doyle, director of marketing – new nutritional ingredients & dietary supplements said: “We’re excited about this new research. This study offers new hope for women who suffer from hot flashes and are seeking a non-hormonal solution but have not had success with black cohosh or other common remedies. This new evidence complements another recent study which showed that a geniVida Bone Blend™ significantly increased bone in the hip of postmenopausal women versus bone loss in those taking a calcium placebo. Together these studies support need to launch new product to meet both short and long term needs of mature women."
